FDA Inspection 1111807 — R-Pharm Germany GmbH
The FDA completed an inspection of R-Pharm Germany GmbH on Aug 1, 2019 in Illertissen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Illertissen (Germany)